Stay updated on Palbociclib After CDK and Endocrine Therapy Clinical Trial

Sign up to get notified when there's something new on the Palbociclib After CDK and Endocrine Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palbociclib After CDK and Endocrine Therapy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:47:26.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A general NIH website-transition notice appears above the ClinicalTrials.gov 403 error page. The displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:49:14.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:57:01.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header, blocking access to the study details and offering only a Home link.
    Difference
    20%
    Check dated 2026-09-23T00:59:50.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Adds background on the three-drug combinations (fulvestrant, palbociclib, and avelumab) and their mechanisms, clarifying the trial’s rationale; also removes duplicated and outdated background text related to the study.
    Difference
    4%
    Check dated 2026-09-16T00:14:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, marking a newer version of the page.
    Difference
    0.0%
    Check dated 2026-09-01T19:34:35.000Z thumbnail image

Stay in the know with updates to Palbociclib After CDK and Endocrine Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palbociclib After CDK and Endocrine Therapy Clinical Trial page.